Breakthrough Discoveries on Cellular Regeneration Seek to Turn Back the Body’s Clock
Nov 7, 2013 - 3:34:07 PM
A team led by Dr. Sean Morrison, Director of CRI and Professor of Pediatrics at UT Southwestern Medical Center, has identified an RNA-binding protein called IMP1 that promotes stem cell self-renewal during fetal development. Self-renewal is the process by which stem cells divide to make more stem cells, which is important for the growth of tissues during fetal development and the regeneration of tissues throughout adult life.
At the same time, researchers including Dr. Hao Zhu, who also directs a lab at CRI and is Assistant Professor of Pediatrics and Internal Medicine at UT Southwestern, have shown that another RNA-binding protein, Lin28a, also promotes tissue repair by reactivating a metabolic state reminiscent of the juvenile developmental stage.
Dr. Zhu's research, published in Cell, showed that reactivation of Lin28a - a gene that is normally turned on in fetal but not adult tissues - substantially improved hair regrowth and accelerated tissue repair after ear and digit injuries.
"Our work found that Lin28a promotes regeneration through a metabolic mechanism," said Dr. Zhu. "This finding opens up an exciting possibility that metabolism could be modulated to improve tissue repair, whereby metabolic drugs could be employed to promote regeneration."
Dr. Morrison's investigation, published in the online journal eLife, identified a set of genes including IMP1 that are turned on only within time-limited windows, and control developmental switches in stem cell properties between fetal development and adulthood.
IMP1 is turned off during late fetal development, partly as a consequence of increasing expression of a third family of RNA-binding molecules called let-7 microRNAs. Importantly, let-7 microRNAs are turned on during late fetal development in part due to declining expression of Lin28a.
Drs. Morrison and Zhu's laboratories both studied molecules at different ends of the same pathway - one that regulates stem cell self-renewal and tissue regeneration by modulating the expression of a network of RNA-binding proteins.
"These results are interesting because let-7-regulated networks were first discovered based on their ability to regulate the timing of developmental transitions in worms," said Dr. Morrison. "This earlier finding suggests that the mechanisms employed by mammalian tissue stem cells to regulate changes in their properties over time are at least partly conserved and depend upon mechanisms inherited from invertebrates."
A previous study from the Morrison laboratory found that expression of let-7 increases throughout adulthood, reducing the activity of stem cells in older animals. The current findings show that IMP1 inhibits the expression of genes that trigger stem cells to commit to specific fates, while promoting the expression of genes related to self-renewal. Further studies are likely to identify many more genetic targets that enable stem cells to adapt their properties to the changing growth and regeneration demands of tissues over an organism's life span.
Together, these studies demonstrate that a network of RNA-binding proteins that are turned on specifically during fetal development promote stem cell function and tissue growth by regulating cellular proliferation and metabolism. The loss of Lin28a and IMP1 expression from adult tissues partly explains why adult tissues no longer grow and have less stem cell function than fetal tissues. Thus, by modulating the function of these pathways in adult stem cells, it may be possible to enhance tissue regeneration.
Dr. Zhu's work was initiated while he was a postdoctoral fellow in Dr. George Daley's laboratory at Boston Children's Hospital. Other members of the Daley laboratory, including Shyh-Chang Ng, contributed to this study, and Dr. Daley was senior author on the paper. The work in the Zhu and Morrison laboratories was supported by the National Institutes of Health and the Cancer Prevention and Research Institute of Texas.
Children's Medical Center Research Institute at UT Southwestern (CRI) is a unique joint venture with a distinct integrative approach to research. Established in 2011, CRI is positioned to build upon the comprehensive clinical expertise of Children's Medical Center of Dallas and the internationally recognized scientific excellence of UT Southwestern Medical Center. CRI's mission is to perform transformative biomedical research to better understand the biological basis of disease, seeking breakthroughs that can change scientific fields and yield new strategies for treating disease. Located in Dallas, Texas, CRI is creating interdisciplinary groups of exceptional scientists and physicians to pursue research at the interface of regenerative medicine, cancer biology and metabolism, fields that hold uncommon potential for discoveries that can yield groundbreaking advances in science and medicine. More information about CRI is available on its website: cri.utsw.edu.
For advertising and promotion on HealthNewsDigest.com, call Mike McCurdy: 877-634-9180 or [email protected] We have over 7,000 journalists as subscribers.